Role of sphingosine kinase 2 in cell migration toward epidermal growth factor

被引:128
作者
Hait, NC
Sarkar, S
Le Stunff, H
Mikami, A
Maceyka, M
Milstien, S
Spiegel, S
机构
[1] Virginia Commonwealth Univ, Sch Med, Dept Biochem, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA
[3] NIMH, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M502922200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine 1-phosphate (S1P), produced by two sphingosine kinase isoenzymes, denoted SphK1 and SphK2, is the ligand for a family of five specific G protein-coupled receptors that regulate cytoskeletal rearrangements and cell motility. Whereas many growth factors stimulate SphK1, much less is known of the regulation of SphK2. Here we report that epidermal growth factor (EGF) stimulated SphK2 in HEK 293 cells. This is the first example of an agonist-dependent regulation of SphK2. Chemotaxis of HEK 293 cells toward EGF was inhibited by N,N-dimethylsphingosine, a competitive inhibitor of both SphKs, implicating S1P generation in this process. Down-regulating expression of SphK1 in HEK 293 cells with a specific siRNA abrogated migration toward EGF, whereas decreasing SphK2 expression had no effect. EGF contributes to the invasiveness of human breast cancer cells, and EGF receptor expression is associated with poor prognosis. EGF also stimulated SphK2 in MDA-MB-453 breast cancer cells. Surprisingly, however, down-regulation of SphK2 in these cells completely eliminated migration toward EGF without affecting fibronectin-induced haptotaxis. Our results suggest that SphK2 plays an important role in migration of MDA-MB-453 cells toward EGF.
引用
收藏
页码:29462 / 29469
页数:8
相关论文
共 59 条
[1]   Extracellular export of sphingosine kinase-1 enzyme - Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation [J].
Ancellin, N ;
Colmont, C ;
Su, J ;
Li, Q ;
Mittereder, N ;
Chae, SS ;
Stefansson, S ;
Liau, G ;
Hla, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6667-6675
[2]   Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells:: role of Bcl-2 expression [J].
Bektas, M ;
Jolly, PS ;
Müller, C ;
Eberle, R ;
Spiegel, S ;
Geilen, CC .
ONCOGENE, 2005, 24 (01) :178-187
[3]   Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate [J].
Dolezalova, H ;
Shankar, G ;
Huang, MC ;
Bikle, DD ;
Goetzl, EJ .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (04) :732-743
[4]   Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells [J].
Duan, HF ;
Wu, CT ;
Lu, Y ;
Wang, H ;
Liu, HJ ;
Zhang, QW ;
Jia, XX ;
Lu, ZZ ;
Wang, LS .
EXPERIMENTAL CELL RESEARCH, 2004, 298 (02) :593-601
[5]   N,N-dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C:: Modulation of cellular levels of sphingosine 1-phosphate and ceramide [J].
Edsall, LC ;
Van Brocklyn, JR ;
Cuvillier, O ;
Kleuser, B ;
Spiegel, S .
BIOCHEMISTRY, 1998, 37 (37) :12892-12898
[6]   Enzymatic measurement of sphingosine 1-phosphate [J].
Edsall, LC ;
Spiegel, S .
ANALYTICAL BIOCHEMISTRY, 1999, 272 (01) :80-86
[7]  
ENDO K, 1991, CANCER RES, V51, P1613
[8]   Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis [J].
English, D ;
Welch, Z ;
Kovala, AT ;
Harvey, K ;
Volpert, OV ;
Brindley, DN ;
Garcia, JGN .
FASEB JOURNAL, 2000, 14 (14) :2255-2265
[9]   Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation [J].
Feistritzer, C ;
Riewald, M .
BLOOD, 2005, 105 (08) :3178-3184
[10]  
French KJ, 2003, CANCER RES, V63, P5962